systemic scleroderma


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to systemic scleroderma: systemic lupus erythematosus

scleroderma

 [skle″ro-der´mah]
chronic hardening and shrinking of the connective tissues of any organ of the body, including the skin, heart, esophagus, kidney, or lung. The skin may be thickened, hard, and rigid, and pigmented patches may occur. The two main types are systemic scleroderma and localized scleroderma. The milder forms are most often seen in women between the ages of 30 and 50; the more severe forms usually affect men, blacks, and older persons. The cause of scleroderma is not known. Current theories suggest three possibilities: an immunological reaction in which the skin attracts lymph cells which stimulate the production of collagen, hereditary factors related to abnormal serum proteins and antinuclear factors, and occupational exposure to silica dust.



Because the symptoms of scleroderma often mimic those of other diseases such as bursitis, osteoarthritis, rheumatoid arthritis, and other collagen disorders, it is difficult to diagnose. There is no test specific for confirmation of a diagnosis of scleroderma, but x-rays, skin biopsies, and tests for antinuclear antibodies, gamma globulin, sedimentation rate, and latex fixation can provide evidence that the disease is present.
Treatment. Treatment includes drugs such as penicillamine, immunosuppressives, and antiinflammatory agents. Ulcers that form on the knuckles, elbows, and other bony prominences as a result of calcium deposits are treated topically with ointments. Physiotherapy to restore and maintain musculoskeletal function as much as possible is indicated for certain patients. For others, diet therapy and small frequent feedings can help relieve the problems of malabsorption due to intestinal involvement.
Patient Care. Patients with scleroderma have especially thick skin that is hard to penetrate with a needle. Injections and venipunctures can be quite painful and should be done with as much care and dispatch as possible. The site of venipuncture for intravenous therapy is monitored frequently, especially for infiltration, which can cause a painful swelling and pressure for weeks. The skin should be protected from irritation that could lead to breakdown and the introduction of infectious agents.



Calcium deposit sites are assessed regularly to note any signs of prolonged pressure, ulceration, or infection. Cool, moist compresses and a topical ointment can help relieve infections when they do develop at these sites. Protection of the respiratory tract includes stopping smoking, avoiding infectious agents, and getting adequate rest. Emotional stress can aggravate the condition; hence patients are taught effective coping strategies and relaxation techniques.

Mouth care and proper brushing and flossing, as well as periodic dental checks, are necessary to prevent cavities and periodontal disease. Patients with scleroderma have great difficulty opening their mouths wide enough to allow dental work to be done. Patients are encouraged to take prescribed medications exactly as ordered and are taught the names of their drugs, their expected action, and when and how to take them, that is, with meals and never with milk products.

Patients and their families can participate better in self-care and management of the illness if they are provided with continued support, either with a group or by a visiting nurse. Additional information about the disease can be obtained by contacting the United Scleroderma Foundation, P.O. Box 399, Watsonville, CA 95077-0399, telephone (800) 722-HOPE.
circumscribed scleroderma
diffuse scleroderma (generalized scleroderma) systemic scleroderma.
linear scleroderma localized scleroderma in a bandlike lesion with discoloration of the skin and atrophy of skin, subcutaneous tissue, muscle, and bone. See also coup de sabre. Called also linear morphea.
localized scleroderma
1. scleroderma confined to the skin and subcutaneous tissue or secondarily involving the musculoskeletal system. It occurs in three forms: morphea, linear scleroderma, and coup de sabre. Called also circumscribed scleroderma.
systemic scleroderma a systemic disorder of the connective tissue characterized by hardening and thickening of the skin, with telangiectasias, Raynaud's phenomenon, and fibrotic degenerative changes in organs such as the heart, lungs, kidneys, and gastrointestinal tract. It may remain confined to the face and hands for a long time or may spread diffusely to become generalized. Called also diffuse or generalized scleroderma and systemic sclerosis. See also CREST syndrome.

scle·ro·der·ma

(sklē'rō-der'mă), Do not confuse this word with scleredema or sclerema.
Thickening and induration of the skin caused by new collagen formation, with atrophy of pilosebaceous follicles; either a manifestation of progressive systemic sclerosis or localized (morphea). See: systemic sclerosis, morphea.
[sclero- + G. derma, skin]

systemic scleroderma

(1) CREST syndrome.
(2) Progressive systemic sclerosis.

scle·ro·der·ma

(sklerō-dĕrmă)
Thickening and induration of the skin caused by new collagen formation, with atrophy of pilosebaceous follicles; either a manifestation of progressive systemic sclerosis or localized (morphea).
Synonym(s): dermatosclerosis, systemic scleroderma.
[sclero- + G. derma, skin]
References in periodicals archive ?
Its first drug candidate, EHP-101, has completed a Phase I clinical study and is being developed for the treatment of multiple sclerosis and systemic scleroderma. Its second, EHP-102, is in preclinical development and is focused on treating Huntington's disease and Parkinson's disease.
Systemic scleroderma and acanthosis nigricans were seen in 1.78 percent and 5.35 percent respectively, whereas in a study by Keen MA et al, 3 they were seen in 0.43 percent and 0.86 percent.
of patients Percentage 1 Urticaria 3 5.35 2 Vitiligo 3 5.35 3 Acanthosis nigricans 3 5.35 4 Melasma 3 5.35 5 Pemphigus foliaceous 1 1.78 6 Systemic scleroderma 1 1.78 7 Xanthalesma palpebrum 1 1.78 8 Lichen planus 1 1.78 Total 16 28.57
Key Words: Antiphospholipids, Systemic scleroderma, Complication, Senegal
These antibodies are either isolated or, most commonly, are associated with an autoimmune disease, in particular systemic lupus, systemic scleroderma (SS), and antiphospholipid syndrome.
Echocardiographic functional assessment of the heart and lipid metabolism in patients with systemic scleroderma and systemic lupus erythematosus.
The simultaneous determination of these autoantibody specificities might be helpful in the differential diagnosis of diseases such as systemic lupus erythematosus, Sjogren syndrome, mixed connective tissue disease, and systemic scleroderma. The application of Copalis technology to the detection of autoantibodies is demonstrated by an assay for the simultaneous detection of antibodies to the autoantigens SSA (Ro) and SSB (La).
announced today that it received from the Minister of Health, Labour and Welfare, a notification of orphan drug designation for human anti-human IL-6 receptor monoclonal antibody "tocilizumab," a drug under development for treatment of systemic scleroderma.
"Systemic scleroderma is a refractory chronic disease with limited therapeutic options and high unmet medical needs.
Commonly called systemic sclerosis (SSc), systemic scleroderma is characterized by proliferative vascular lesions; fibrosis of internal organs, including the lungs, heart, kidneys, and gastrointestinal tract; and distinct cutaneous manifestations.
-- The most significant predictor of progression to systemic scleroderma in a patient with new-onset Raynaud's phenomenon is the presence of capillary abnormalities at the proximal nail fold, according to David H.
Systemic scleroderma is a chronic autoimmune disease involving sclerotic, vascular, and inflammatory changes of the skin and internal organs.